Back

Efficacy and safety of the ultraslow low-dose thrombolytic regimen for mechanical prosthetic valve thrombosis: a prospective cohort study

30 August 2024 (09:00 - 09:40)
Organised by: Logo
Congress Presentation Part of: Prosthetic heart valves: preventing thrombosis and stroke Prosthetic Heart Valves ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Parham Sadeghipour

Rajaie Cardioascular Instiute, Tehran (Iran (Islamic Republic of))

6 More presentations in this session

Presentation thumbnail
Impact of protruding and ulcerated aortic atheroma on periprocedural ischemic stroke in patients undergoing transcatheter aortic valve replacement: a comprehensive analysis
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Association between silent cerebral embolism and cognitive alterations following transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valve patients
Doctor Y. Huang (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Anticoagulation control challenges in patients with rheumatic heart disease and mechanical heart valves operated at a cardiac surgery center in a low-income country
Mrs C. Nhavoto (Maputo, MZ)
Abstract Slides Video
Presentation thumbnail
Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis
Doctor R. Chopard (Besancon, FR)
Abstract Slides Video
Presentation thumbnail
Temporal trends in antithrombotic therapy following transcatheter aortic valve implantation in denmark
Ms H. Vistisen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Prosthetic heart valves: preventing thrombosis and stroke

The Event

Event poster

ESC Congress 2024

30 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial
thumbnail
Congress Presentation
Management of prosthetic mitral valve thrombosis: the role of repeated low-dose thrombolysis
thumbnail
Congress Presentation
Recombinant tissue plasminogen activator as a modifier of treatment effect in prosthetic valve thrombosis: systematic review and meta-regression

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources